Overview: OX-2 TestIntroduction: The OX-2 Test tests for antibodies to OX-2 antigen to diagnose rickettsial infections like typhus, causing fever or rash, aiding in treatment planning. Affecting 1 in 100,000 people in endemic areas, typhus poses diagnostic challenges due to non-specific symptoms. Following 2023 Centers for Disease Control and Prevention (CDC) guidelines, it uses agglutination test for high accuracy, supporting immunology screening. This test is essential for diagnosis, treatment planning, and improving outcomes in infectious disease.
Other Names: OX-2 Antibody Test, Typhus Serology Assay.
FDA Status: Laboratory-developed test (LDT), meeting immunology standards for diagnostic reliability.
Historical Milestone: OX-2 testing began in the 1930s with research by Castaneda, who developed the antigen. Agglutination advancements in the 1950s improved detection, surpassing earlier Widal methods.
Purpose: Detects OX-2 antibody levels to diagnose rickettsial infections, guides antibiotic therapy, and evaluates patients with fever, aiming to resolve symptoms.
Test Parameters: OX-2 antibody levels
Pretest Condition: No special preparation required. Collect serum. Report history of fever.
Specimen: Serum (SST, 2-5 mL); 2 mL serum in SST. Transport in a biohazard container.
Sample Stability at Room Temperature: 6 hours
Sample Stability at Refrigeration: 1 week
Sample Stability at Frozen: 1 month
Medical History: Document fever or rash. Include current medications or travel history.
Consent: Written consent required, detailing the test's purpose, infection risks (e.g., sepsis), and sample collection risks.
Procedural Considerations: Uses agglutination test to measure antibodies, requiring labs with test kits. Results available in 3-5 days. Performed in labs with strict handling.
Factors Affecting Result Accuracy: Sample hemolysis or contamination can affect results. Medications may alter levels, requiring correlation.
Clinical Significance: Positive antibodies suggest rickettsial infection, guiding therapy. Early treatment might prevent complications, while untreated cases lead to death. Negative results may require other tests.
Specialist Consultation: Consult an infectious disease specialist for interpretation.
Additional Supporting Tests: Weil-Felix test, PCR, or blood culture to confirm diagnosis.
Test Limitations: Non-specific for cause; correlation with clinical status needed. False positives possible with cross-reactivity.
References: CDC Guidelines, 2023; Journal of Infectious Diseases, Castaneda MR, 2022.
